Author
Listed:
- Sidi A. Bencherif
(School of Engineering and Applied Sciences, Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University
Sorbonne University, UTC CNRS UMR 7338, Biomechanics and Bioengineering (BMBI), University of Technology of Compiègne)
- R. Warren Sands
(School of Engineering and Applied Sciences, Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University
University of Pittsburgh Medical Center Department of Medicine)
- Omar A. Ali
(School of Engineering and Applied Sciences, Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Weiwei A. Li
(School of Engineering and Applied Sciences, Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Sarah A. Lewin
(School of Engineering and Applied Sciences, Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Thomas M. Braschler
(School of Engineering and Applied Sciences, Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University
School of Engineering, LMIS4, Station 17, École polytechnique fédérale de Lausanne)
- Ting-Yu Shih
(School of Engineering and Applied Sciences, Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Catia S. Verbeke
(School of Engineering and Applied Sciences, Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Deen Bhatta
(School of Engineering and Applied Sciences, Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Glenn Dranoff
(Brigham and Women’s Hospital and Harvard Medical School)
- David J. Mooney
(School of Engineering and Applied Sciences, Harvard University
Wyss Institute for Biologically Inspired Engineering at Harvard University)
Abstract
A biomaterial-based vaccination system that uses minimal extracorporeal manipulation could provide in situ enhancement of dendritic cell (DC) numbers, a physical space where DCs interface with transplanted tumour cells, and an immunogenic context. Here we encapsulate GM-CSF, serving as a DC enhancement factor, and CpG ODN, serving as a DC activating factor, into sponge-like macroporous cryogels. These cryogels are injected subcutaneously into mice to localize transplanted tumour cells and deliver immunomodulatory factors in a controlled spatio-temporal manner. These vaccines elicit local infiltrates composed of conventional and plasmacytoid DCs, with the subsequent induction of potent, durable and specific anti-tumour T-cell responses in a melanoma model. These cryogels can be delivered in a minimally invasive manner, bypass the need for genetic modification of transplanted cancer cells and provide sustained release of immunomodulators. Altogether, these findings indicate the potential for cryogels to serve as a platform for cancer cell vaccinations.
Suggested Citation
Sidi A. Bencherif & R. Warren Sands & Omar A. Ali & Weiwei A. Li & Sarah A. Lewin & Thomas M. Braschler & Ting-Yu Shih & Catia S. Verbeke & Deen Bhatta & Glenn Dranoff & David J. Mooney, 2015.
"Injectable cryogel-based whole-cell cancer vaccines,"
Nature Communications, Nature, vol. 6(1), pages 1-13, November.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8556
DOI: 10.1038/ncomms8556
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Ying Zhang & Raghava N. Sriramaneni & Paul A. Clark & Justin C. Jagodinsky & Mingzhou Ye & Wonjong Jin & Yuyuan Wang & Amber Bates & Caroline P. Kerr & Trang Le & Raad Allawi & Xiuxiu Wang & Ruosen Xi, 2022.
"Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade,"
Nature Communications, Nature, vol. 13(1), pages 1-17, December.
- Kwasi Adu-Berchie & Joshua M. Brockman & Yutong Liu & Tania W. To & David K. Y. Zhang & Alexander J. Najibi & Yoav Binenbaum & Alexander Stafford & Nikolaos Dimitrakakis & Miguel C. Sobral & Maxence O, 2023.
"Adoptive T cell transfer and host antigen-presenting cell recruitment with cryogel scaffolds promotes long-term protection against solid tumors,"
Nature Communications, Nature, vol. 14(1), pages 1-15, December.
- Jiaqi Meng & Yanlin Lv & Weier Bao & Zihui Meng & Shuang Wang & Yuanbin Wu & Shuping Li & Zhouguang Jiao & Zhiyuan Tian & Guanghui Ma & Wei Wei, 2023.
"Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation,"
Nature Communications, Nature, vol. 14(1), pages 1-17, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms8556. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.